IDiyas

For the Inventor, By the Inventor

San Diego, CA, United States of America

Jason Conrad Pickens

USPTO Granted Patents = 15


Average Co-Inventor Count = 11.2

ph-index = 4

Forward Citations = 62(Granted Patents)


Location History:

  • Chula Vista, CA (US) (2014 - 2017)
  • San Diego, CA (US) (2011 - 2023)

Company Filing History:

goldMedal12 out of 134 
 
Ligand Pharmaceuticals, Inc.
 patents
silverMedal3 out of 8 
 
Chembridge Corporation
 patents

Years Active: 2011-2023

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 11773110 - Heterocycle amines and uses thereof (2023-10-03),
2. 11413274 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2022-08-16),
3. 11186593 - Heterocycle amines and uses thereof (2021-11-30),
4. 10736875 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2020-08-11),
5. 10604533 - Heterocycle amines and uses thereof (2020-03-31),
6. 10111859 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2018-10-30),
7. 10030034 - Heterocycle amines and uses thereof (2018-07-24),
8. 9622991 - Hematopoietic growth factor mimetic small molecule compounds and their uses (2017-04-18),
9. 9492430 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2016-11-15),
10. 9266874 - Heterocycle amines and uses thereof (2016-02-23),
11. 9144557 - Hematopoietic growth factor mimetic small molecule compounds and their uses (2015-09-29),
12. 8815906 - Tyrosine kinase inhibitors (2014-08-26),
13. 8680150 - Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors (2014-03-25),
14. 8629147 - Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders (2014-01-14),
15. 8063225 - Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders (2011-11-22),

Title: The Innovator Behind Chemical and Medicinal Breakthroughs: Jason Conrad Pickens

Introduction:

Jason Conrad Pickens, a renowned inventor based in San Diego, CA, has made significant contributions to the fields of chemistry and medicine. With an impressive portfolio of 15 patents, his work has paved the way for advancements in treating inflammatory disorders and neurological conditions.

Latest Patents:

Among his latest patents is "Heterocycle Amines and Uses Thereof", which unveils groundbreaking compounds and methods with applications in chemistry and medicine. These discoveries include heterocycle amines that show promise in addressing inflammatory disorders. Additionally, Pickens has delved into the realm of granulocyte colony-stimulating factor receptor (GCFR) with methods and compositions aimed at treating hematopoietic and neurological disorders.

Career Highlights:

Throughout his career, Jason Conrad Pickens has played pivotal roles at distinguished companies such as Ligand Pharmaceuticals, Inc., and Chembridge Corporation. These esteemed organizations have provided him with platforms to harness his innovative prowess and translate it into tangible solutions.

Collaborations:

Collaboration lies at the heart of Pickens' success, with notable coworkers like Lin Zhi and Yixing Shen contributing to his groundbreaking research. Together, they have tackled complex challenges in the realms of chemistry and medicine, propelling the boundaries of innovation forward.

Conclusion:

In conclusion, Jason Conrad Pickens stands as a trailblazer in the fields of chemistry and medicine, with a remarkable track record of patents and collaborations that have reshaped the landscape of scientific discovery. His dedication to advancing healthcare and improving patient outcomes underscores his unwavering commitment to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…